Israel Englander’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,843
Closed -$147K 6271
2025
Q4
$147K Sell
20,843
-4,486
-18% -$40.1K ﹤0.01% 5552
2025
Q3
$288K Sell
25,329
-1,541
-6% -$29.7K ﹤0.01% 5356
2025
Q2
$621K Buy
26,870
+26,688
+14,664% +$745K ﹤0.01% 4747
2025
Q1
$7.9K Buy
+182
New +$11.6K ﹤0.01% 5696
2024
Q2
Sell
-3,670
Closed -$778K 6421
2024
Q1
$778K Buy
3,670
+2,091
+132% +$564K ﹤0.01% 4513
2023
Q4
$400K Sell
1,579
-818
-34% -$224K ﹤0.01% 4782
2023
Q3
$857K Sell
2,397
-746
-24% -$113K ﹤0.01% 4292
2023
Q2
$142K Buy
3,143
+2,683
+583% +$206K ﹤0.01% 5241
2023
Q1
$34K Sell
460
-200
-30% -$17.6K ﹤0.01% 5737
2022
Q4
$54K Buy
660
+245
+59% +$32.9K ﹤0.01% 5754
2022
Q3
$60K Sell
415
-512
-55% -$93.3K ﹤0.01% 6125
2022
Q2
$143K Sell
927
-1,408
-60% -$644K ﹤0.01% 5786
2022
Q1
$1.54M Buy
2,335
+1,529
+190% +$814K ﹤0.01% 4106
2021
Q4
$470K Buy
+806
New +$585K ﹤0.01% 5105
2021
Q3
Sell
-1,458
Closed -$580K 7165
2021
Q2
$580K Buy
+1,458
New +$475K ﹤0.01% 5157
2020
Q4
Sell
-452
Closed -$129 5520
2020
Q3
$129 Buy
+452
New +$142K ﹤0.01% 4181
2020
Q2
Sell
-137
Closed -$33K 4528
2020
Q1
$33K Buy
+137
New +$40.7K ﹤0.01% 3704
2019
Q4
Sell
-345
Closed -$151K 4566
2019
Q3
$151K Sell
345
-642
-65% -$246K ﹤0.01% 3869
2019
Q2
$355K Buy
987
+30
+3% +$14.6K ﹤0.01% 3448
2019
Q1
$531K Buy
+957
New +$559K ﹤0.01% 3226

Other funds holding LNAI

Israel Englander's LNAI Position: Q1 2026 in Review

Israel Englander sold out of Lunai Bioworks (LNAI) in Q1 2026, closing a stake of 20,843 shares — an estimated $147K sold.

Israel Englander first reported a position in LNAI in Q1 2019 and held it in 20 quarters. The position peaked at $1.54M in Q1 2022. 27 funds tracked by Wall St. Rank hold LNAI as of Q1 2026.

  • Israel Englander reported no remaining Lunai Bioworks position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 20,843 Lunai Bioworks shares in Q1 2026, an estimated $147K.
  • Israel Englander first reported a position in Lunai Bioworks in Q1 2019 and held it in 20 quarters.
  • Israel Englander's Lunai Bioworks position peaked at $1.54M in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.